What is the proper dosing and usage of Trazodone (antidepressant) for regular treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trazodone Dosing for Antidepressant Treatment

For antidepressant treatment, trazodone should be initiated at 150 mg/day in divided doses and gradually increased based on clinical response, with a maximum outpatient dose of 400 mg/day and inpatient dose of 600 mg/day. 1

Initial Dosing and Titration

  • Start with 150 mg/day in divided doses 1
  • Increase by 50 mg/day every 3-4 days as needed based on clinical response and tolerability 1
  • Take shortly after a meal or light snack to improve absorption 1
  • Can be swallowed whole or administered as a half tablet by breaking along the score line 1

Maximum Dosing

  • Outpatients: Maximum dose should not exceed 400 mg/day in divided doses 1
  • Inpatients (more severely depressed patients): Up to 600 mg/day in divided doses 1
  • Elderly patients: Maximum tolerated doses are typically 300-400 mg/day 2

Administration Schedule Options

  • Traditional divided dosing: Multiple doses throughout the day 3
  • Single nighttime dosing: Studies show equal efficacy for depression relief when given predominantly at bedtime 3
  • Bedtime-weighted dosing: 150 mg given predominantly at bedtime, increased as needed to 200-300 mg for full antidepressant efficacy 3
  • Consider administering a major portion of the daily dose at bedtime if drowsiness occurs 1

Duration of Treatment

  • A full therapeutic trial requires at least 4-8 weeks 4
  • Dosage should be increased using increments of initial dose every 5-7 days until therapeutic benefits or significant side effects become apparent 4
  • Once an adequate response has been achieved, dosage may be gradually reduced, with subsequent adjustment depending on therapeutic response 1

Special Considerations

Screening and Monitoring

  • Screen patients for personal or family history of bipolar disorder, mania, or hypomania prior to initiating treatment 1
  • After 9 months, consider dosage reduction to reassess the need for medication 4

Drug Interactions

  • At least 14 days must elapse between discontinuation of a monoamine oxidase inhibitor (MAOI) and initiation of trazodone 1
  • Consider reducing trazodone dose when coadministered with strong CYP3A4 inhibitors 1
  • Consider increasing trazodone dose when coadministered with strong CYP3A4 inducers 1

Discontinuation

  • Gradually reduce the dosage rather than stopping trazodone abruptly to avoid discontinuation symptoms 1
  • Discontinuing trazodone over 10-14 days limits withdrawal symptoms 4

Side Effects and Precautions

  • Most common side effect is sedation/drowsiness 3, 5
  • Other potential side effects include dizziness, gastrointestinal dysfunction, and dry mouth 5
  • Monitor for orthostatic hypotension, especially in elderly patients 2
  • Use with caution in patients with premature ventricular contractions 4
  • Priapism has been reported as a rare but serious side effect 2

Efficacy Profile

  • Trazodone has been shown to be as effective as other antidepressants including amitriptyline, imipramine, fluoxetine, and mianserin in relieving depressive symptoms 2
  • Particularly beneficial for patients with depression accompanied by anxiety and insomnia due to its sedative properties 6
  • May be helpful for patients who are unresponsive to or cannot tolerate therapy with other antidepressants 2

Special Populations

  • Elderly patients may benefit from lower starting doses and slower titration 5
  • Has been successfully used in patients with depression and pre-existing cardiovascular disease 2
  • Has lower incidence of anticholinergic and cardiovascular effects compared to older tricyclic antidepressants in elderly patients 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.